The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Morning Seminar

MS2-3 Therapeutic Strategy 2020 for Multiple Myeloma ~Aiming for deeper responses~

Sat. Oct 12, 2019 7:55 AM - 8:40 AM No.3 (Tokyo International Forum, 7F Hall B7(2))

Chair: MASAHIRO ABE（Department of Hematology, Endocrinology and Metabolism, Tokushima University, Japan）

Sponsor: ONO PHARMACEUTICAL CO., LTD.

[MS2-3] Therapeutic Strategy 2020 for Multiple Myeloma ~Aiming for deeper responses~

TADAO ISHIDA (Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password